ÍøºìºÚÁÏ

Skip to main content

Joanne Lagmay, MD

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of Joanne Lagmay

Research at a glance

Top areas of exploration

  • Biomarkers, Tumor , 6 publications
  • Bone Neoplasms , 5 publications
  • Neoplasm Recurrence, Local , 5 publications
  • Osteosarcoma , 4 publications

Research activity

28 publications

441 citations

Why is this important?

Active clinical trials

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

This is a prospective, multicenter clinical trial in subjects with newly diagnosed high-risk neuroblastoma to evaluate the efficacy and safety of administering naxitamab with standard induction therapy. The initial chemotherapy will include 5 cycles…

Investigator
Joanne Lagmay
Status
Accepting Candidates
Ages
12 Months - 21 Years
Sexes
All

My publications

28 publications

2025

"Somewhat of an Adult": Understanding the "Dance" of Competing Tensions Parents Manage While Caring for an Adolescent or Young Adult (AYA) Diagnosed with Hematologic Malignancy.

Cancers

•

2025

Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries.

Cancer

•

2024

Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma.

Cancer journal (Sudbury, Mass.)

•

2024

Investigating surface proteins and antibody combinations for detecting circulating tumor cells of various sarcomas.

Scientific reports

•

2024

Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation.

Clinical cancer research : an official journal of the American Association for Cancer Research

•